|
TRNT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.214800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.417200E-03 |
| Normal-vs-Stage2 |
1.765400E-01 |
| Normal-vs-Stage3 |
2.760700E-04 |
| Normal-vs-Stage4 |
1.74067999999528E-05 |
| Stage1-vs-Stage2 |
3.726400E-01 |
| Stage1-vs-Stage3 |
8.251800E-02 |
| Stage1-vs-Stage4 |
1.549820E-02 |
| Stage2-vs-Stage3 |
6.093700E-02 |
| Stage2-vs-Stage4 |
1.154280E-02 |
| Stage3-vs-Stage4 |
3.346000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.645900E-04 |
| Normal-vs-AfricanAmerican |
6.45830000000069E-05 |
| Normal-vs-Asian |
5.978200E-01 |
| Caucasian-vs-AfricanAmerican |
6.965800E-02 |
| Caucasian-vs-Asian |
1.062220E-02 |
| AfricanAmerican-vs-Asian |
2.763100E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99850000000201E-05 |
| Normal-vs-Female |
4.804800E-03 |
| Male-vs-Female |
4.218000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.343100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.018600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.610700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.123700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.133600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.247970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.449200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.291400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.341400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.206600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.696000E-01 |
| Classical-VS-Follicular |
8.009400E-01 |
| Classical-VS-Other |
3.865200E-01 |
| Classical-VS-Normal |
2.721300E-03 |
| Tall-VS-Follicular |
2.168400E-01 |
| Tall-VS-Other |
7.541800E-01 |
| Tall-VS-Normal |
1.924200E-03 |
| Follicular-VS-Other |
4.334400E-01 |
| Follicular-VS-Normal |
3.498000E-02 |
| Other-VS-Normal |
4.649500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.657600E-03 |
| Normal-vs-N1 |
1.062010E-02 |
| N0-vs-N1 |
7.879000E-01 |
|
|
